Stocks posted their first monthly decline since January during September as rising prices from food to energy stoked concerns that central banks may have to raise interest rates just as an economic recovery is losing steam.
Stocks rose for a seventh straight month during August, amid ongoing optimism that the global economy continues to rebound from the COVID-19 slump and as the US Federal Reserve indicated it won’t rush to raise interest rates.
Stocks rose for a sixth straight month during July, as ongoing optimism that the global economy and corporate profits are rebounding outweighed concerns about a reacceleration of the COVID-19 pandemic.
Stocks rose for a fourth consecutive month in May, with the STOXX® Global 1800 Index extending its all-time high, as countries lifted restrictions put in place to control the spread of the COVID-19 pandemic.
Stocks extended gains in March as countries pushed ahead with their COVID-19 vaccine rollouts, the US passed a new stimulus package and major central banks indicated they are likely to keep interest rates low even as the economy rebounds.
Stocks climbed in February on continued hopes for a post-lockdown economic recovery. Benchmark indices pared more than half of their advance at the end of the month following a spike in bond yields and inflation expectations.
The STOXX® Global 1800 Index rose 4.3% in dollars in December, cementing a second straight year of double-digit percentage gains, as investors raised expectations that policy support and vaccines will help economies overcome the COVID-19-induced slump.
The STOXX® Global 1800 Index surged 12.9% in dollars in November, its largest monthly increase since data begins in 2004, as three drugs manufacturers announced their experimental vaccines are widely effective in preventing the COVID-19 virus.